[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @biotech_brian Brian H Yang Brian H Yang posts on X about china, $smmt the most. They currently have XXX followers and XX posts still getting attention that total X engagements in the last XX hours. ### Engagements: X [#](/creator/twitter::17910191/interactions)  - X Week XXX +1,407% - X Month XXX +26% - X Months XXXXX -XX% - X Year XXXXX +22,872% ### Mentions: X [#](/creator/twitter::17910191/posts_active)  - X Week X +67% - X Month X +13% - X Months XX +19% - X Year XX +5,600% ### Followers: XXX [#](/creator/twitter::17910191/followers)  - X Week XXX +0.18% - X Month XXX no change - X Months XXX +4.40% ### CreatorRank: undefined [#](/creator/twitter::17910191/influencer_rank)  ### Social Influence [#](/creator/twitter::17910191/influence) --- **Social category influence** [countries](/list/countries) **Social topic influence** [china](/topic/china), [$smmt](/topic/$smmt) **Top assets mentioned** [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) ### Top Social Posts [#](/creator/twitter::17910191/posts) --- Top posts by engagements in the last XX hours "BeiGene thrived when founders joined forces with professional CEOs and BD leaders Xiaodong Wang & John Oyler but when should a biotech involve professional ##ChinaBiotech #Leadership #ScalingUp" [X Link](https://x.com/biotech_brian/status/1971627082750087643) [@biotech_brian](/creator/x/biotech_brian) 2025-09-26T17:25Z XXX followers, XX engagements "China innovation in biotech does happen overnight $SMMT Tx partner Akeso CEO Michelle Xia noted during #STATSummit in Boston" [X Link](https://x.com/biotech_brian/status/1978564350651646061) [@biotech_brian](/creator/x/biotech_brian) 2025-10-15T20:51Z XXX followers, XXX engagements "The latest ivonescimab data from #ESMO25 reinforces what Akeso CEO Xia noted during #STATSummit STATSummit last week that more scrutiny over data from China is anticipated but the quality has improved since Beijings ICH membership in 2017" [X Link](https://x.com/biotech_brian/status/1980310615005753630) [@biotech_brian](/creator/x/biotech_brian) 2025-10-20T16:30Z XXX followers, XX engagements "Interesting Junshis JS207 faces off Opdivo while Akeso picks tislelizumab. What is the rational GM Dr. Zuo pointed Opdivo being first I/O success gives JS207 good references as the potential I/O XXX leader" [X Link](https://x.com/biotech_brian/status/1980313435419341102) [@biotech_brian](/creator/x/biotech_brian) 2025-10-20T16:41Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@biotech_brian Brian H YangBrian H Yang posts on X about china, $smmt the most. They currently have XXX followers and XX posts still getting attention that total X engagements in the last XX hours.
Social category influence countries
Social topic influence china, $smmt
Top assets mentioned Summit Therapeutics Inc. Common Stock (SMMT)
Top posts by engagements in the last XX hours
"BeiGene thrived when founders joined forces with professional CEOs and BD leaders Xiaodong Wang & John Oyler but when should a biotech involve professional ##ChinaBiotech #Leadership #ScalingUp"
X Link @biotech_brian 2025-09-26T17:25Z XXX followers, XX engagements
"China innovation in biotech does happen overnight $SMMT Tx partner Akeso CEO Michelle Xia noted during #STATSummit in Boston"
X Link @biotech_brian 2025-10-15T20:51Z XXX followers, XXX engagements
"The latest ivonescimab data from #ESMO25 reinforces what Akeso CEO Xia noted during #STATSummit STATSummit last week that more scrutiny over data from China is anticipated but the quality has improved since Beijings ICH membership in 2017"
X Link @biotech_brian 2025-10-20T16:30Z XXX followers, XX engagements
"Interesting Junshis JS207 faces off Opdivo while Akeso picks tislelizumab. What is the rational GM Dr. Zuo pointed Opdivo being first I/O success gives JS207 good references as the potential I/O XXX leader"
X Link @biotech_brian 2025-10-20T16:41Z XXX followers, XX engagements
/creator/twitter::biotech_brian